What to Expect from Async Telehealth Peptide Therapy

What asynchronous telehealth means

Asynchronous telehealth, sometimes called "store-and-forward" telehealth, is a care model where you submit your medical information on your own time and a licensed clinician reviews it without a live video or phone call. You and your clinician do not need to be available at the same moment. You provide your information when it is convenient, and the clinician reviews it during their clinical hours.

This model has been used in dermatology, radiology, and pathology for years, where a provider reviews images, lab results, or clinical photographs submitted by the patient or another provider. The American Telemedicine Association recognizes asynchronous telehealth as a legitimate care delivery model when the clinical decision can be made based on submitted information without requiring a real-time physical examination.

For peptide therapy specifically, the async model is well suited because the key clinical decisions, safety screening, contraindication review, lab evaluation, and protocol selection, depend on information that can be documented and reviewed rather than physically examined. Your surgical site does not need to be visually inspected by the prescribing clinician. What matters is your surgical history, your medical history, your current medications, and your laboratory values.

What you submit during intake

A thorough async intake for peptide therapy typically includes several categories of information.

Surgical details: the type of surgery you had, the date, the specific procedure performed (for example, whether an ACL reconstruction used a hamstring autograft versus a patellar tendon autograft), and any complications during or after the procedure. This information helps the clinician understand the biological demands of your recovery and which tissues are involved.

Medical history: current and past medical conditions, medications (including over-the-counter supplements), allergies, prior surgeries, and family history of relevant conditions. History of cancer or autoimmune conditions is particularly important given the angiogenic mechanism of some recovery peptides and the immune-modulating effects of others.

Recovery status: your current symptoms, how your rehabilitation is progressing, any persistent pain or swelling, and what your goals are. A patient three weeks out from a rotator cuff repair with persistent inflammation and limited range of motion presents a different clinical picture than a patient eight weeks out who is progressing well through physical therapy but interested in optimizing collagen remodeling.

Laboratory results: recent blood work, ideally including a comprehensive metabolic panel, complete blood count with differential, and inflammatory markers like CRP and ESR. These results help the clinician assess your baseline health, identify contraindications, and determine whether immune modulation is appropriate. If labs are not recent enough or are incomplete, the clinician may request updated testing before making a prescription decision.

Peptide preferences: you can indicate which peptides you are interested in or have researched, but the clinician makes the final determination based on your clinical picture. A patient requesting BPC-157 who has a history of cancer, for example, would warrant a careful conversation about the theoretical angiogenesis concern before any prescription is written.

How clinical review works

A licensed clinician reviews your complete submission. This is not a rubber stamp. The review involves evaluating your surgical and medical history for contraindications, assessing whether your recovery timeline and symptoms suggest that peptide support is clinically appropriate, selecting the peptide or combination that matches your surgical biology and recovery phase, determining dosing and duration based on the preclinical evidence and clinical experience, and documenting the clinical rationale.

The clinician may approve a prescription, request additional information or labs, or decline the consultation if peptide therapy is not appropriate for your situation. Declining is a feature, not a failure. It means the clinical process is working as intended. If you are not approved, you receive a full refund.

After approval

If a prescription is issued, you can order the compounded peptide through your patient portal. Product is shipped from a US-licensed compounding pharmacy with full traceability, including a batch-specific Certificate of Analysis. Shipping follows cold-chain protocols where required by the compound.

Follow-up reviews are scheduled based on your protocol. These check-ins allow the clinician to assess your progress, adjust dosing if needed, and determine whether the protocol should continue, be modified, or be concluded.

Why this model exists

The async model exists because it removes the barriers that prevent many post-surgical patients from accessing clinical oversight for peptide use. Many patients interested in peptides are self-sourcing from grey-market vendors without any clinical involvement, which introduces quality and safety risks. By making the clinical evaluation accessible, without requiring in-person visits or real-time scheduling, the async model brings the clinical oversight component into the process for patients who would otherwise go without it.

This is not a replacement for your surgeon's care. It is a complementary clinical relationship focused specifically on peptide therapy, operating alongside your existing surgical and rehabilitation team.